CONCLUSION: Lower sputum galectin-7 levels are associated with later stages and an increased risk of future acute exacerbations in COPD, suggesting that galectin-7 may be a promising biomarker related to disease severity and prognosis. Here, LGALS7 is linked to chronic obstructive pulmonary disease.